PEB:NZE
Pacific Edge Ltd
NZ$ ०.२४
०.००%
(०.००) 1D
अक्टोबर १६, १६:५९:४६ GMT+१३ · NZD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEB...
Open
NZ$ ०.२४
High
NZ$ ०.२४
Low
NZ$ ०.२४
Mkt. cap
२८.५६ करोड
Avg. vol.
६.९७ लाख
Volume
७.६२ लाख
52-wk high
NZ$ ०.३४
52-wk low
NZ$ ०.१४
EPS
-NZ$ ०.०४
Shares outstanding
१.२४ अरब
No. of employees
११४
Open
NZ$ ०.२४
High
NZ$ ०.२४
Low
NZ$ ०.२४
Mkt. cap
२८.५६ करोड
Avg. vol.
६.९७ लाख
Volume
७.६२ लाख
52-wk high
NZ$ ०.३४
52-wk low
NZ$ ०.१४
EPS
-NZ$ ०.०४
Shares outstanding
१.२४ अरब
No. of employees
११४
News stories
From web sources and news partners
Business Wire
·
३४ मिनेट पहिले
Power Integrations Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
१ घण्टा पहिले
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance
·
१ घण्टा पहिले
Kopin to Host Live YouTube "Ask Me Anything" Panel from Nasdaq MarketSite on the Future of AI Infrastructure
CNN
·
२ घण्टा पहिले
Nasdaq sinks more than 2% as investors raise questions about AI debt
Profile
Pacific Edge Limited, based in New Zealand, focuses on cancer diagnostics with a suite of bladder cancer diagnostic tools using genetic biomarkers. The company operates with a head office in Dunedin, New Zealand, and also has an office in Hershey, USA. It is listed on the Australian ASX and the New Zealand NZX main board stock exchange. Wikipedia
About Pacific Edge Ltd